Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 63 days

Cancer Drug Resistance

Articles

Most Recent | Most Viewed | Most Downloaded

Recent advanced lipid-based nanomedicines for overcoming cancer resistance

Open Access Review DOI: 10.20517/cdr.2024.19 20 Jun 2024
Views: Downloads:
Download PDF

The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer

Open Access Review DOI: 10.20517/cdr.2023.120 10 Jun 2024
Views: Downloads:
Download PDF

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer

Open Access Review DOI: 10.20517/cdr.2024.06 2 Jun 2024
Views: Downloads:
Download PDF

Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients

Open Access Original Article DOI: 10.20517/cdr.2024.10 23 May 2024
Views: Downloads:
Download PDF

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

Open Access Review DOI: 10.20517/cdr.2024.25 22 May 2024
Views: Downloads:
Download PDF

Venetoclax resistance: mechanistic insights and future strategies

Open Access Review DOI: 10.20517/cdr.2021.125 5 May 2022
Views: Downloads:
Download PDF

Improving HER2 testing reproducibility in HER2-low breast cancer

Open Access Opinion DOI: 10.20517/cdr.2022.29 31 Aug 2022
Views: Downloads:
Download PDF

Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces

Open Access Review DOI: 10.20517/cdr.2022.20 1 Aug 2022
Views: Downloads:
Download PDF

Submission Deadline: 28 Feb 2025

Published articles: 0

Topic: Pioneering Strategies to Combat Drug Resistance in Prostate Cancer

Submission Deadline: 15 Jan 2025

Published articles: 0

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
We are pleased to announce that our journal, Cancer Drug Resistance (CDR), has obtained a new Impact Factor 2023 of 4.6, as reported by the Journal Citation Reports (JCR) released by Clarivate Analytics on June 20, 2024.
placing the journal in Q1 in the Pharmacology (medical) discipline
We consistently welcome suggestions for improvements from both readers and authors (send an e-mail to preprint@scierxiv.com).
Their promotion recognizes their exceptional contributions to the journal and their steadfast dedication to advancing research in the field of cancer drug resistance.
We are delighted to announce the promotion of Prof. Yehuda G Assaraf to the position of Co-Editor-in-Chief of CDR juornal
Join CDR Journal's Junior Editorial Board for a Pioneering Academic Experience

Submission Deadline: 28 Feb 2025

Published articles: 0

Topic: Pioneering Strategies to Combat Drug Resistance in Prostate Cancer

Submission Deadline: 15 Jan 2025

Published articles: 0

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/